Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.

Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.

Uncontrolled studies of mesenchymal stem cells (MSCs) in multiple sclerosis suggested some beneficial effect. In this randomized, double-blind, placebo-controlled, crossover phase II study we investigated their safety and efficacy in relapsing-remitting multiple sclerosis patients. Efficacy was eval...

Full description

Bibliographic Details
Main Authors: Sara Llufriu, María Sepúlveda, Yolanda Blanco, Pedro Marín, Beatriz Moreno, Joan Berenguer, Iñigo Gabilondo, Eloy Martínez-Heras, Nuria Sola-Valls, Joan-Albert Arnaiz, Enrique J Andreu, Begoña Fernández, Santi Bullich, Bernardo Sánchez-Dalmau, Francesc Graus, Pablo Villoslada, Albert Saiz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4250058?pdf=render

Similar Items

Similar Items